Form preview

Get the free Emergency Use Authorization for Peramivir

Get Form
This document authorizes the emergency use of the unapproved drug peramivir for the treatment of 2009 H1N1 influenza virus in certain adult and pediatric patients, clarifying dosing recommendations
We are not affiliated with any brand or entity on this form

Get, Create, Make and Sign emergency use authorization for

Edit
Edit your emergency use authorization for form online
Type text, complete fillable fields, insert images, highlight or blackout data for discretion, add comments, and more.
Add
Add your legally-binding signature
Draw or type your signature, upload a signature image, or capture it with your digital camera.
Share
Share your form instantly
Email, fax, or share your emergency use authorization for form via URL. You can also download, print, or export forms to your preferred cloud storage service.

Editing emergency use authorization for online

9.5
Ease of Setup
pdfFiller User Ratings on G2
9.0
Ease of Use
pdfFiller User Ratings on G2
Here are the steps you need to follow to get started with our professional PDF editor:
1
Create an account. Begin by choosing Start Free Trial and, if you are a new user, establish a profile.
2
Prepare a file. Use the Add New button. Then upload your file to the system from your device, importing it from internal mail, the cloud, or by adding its URL.
3
Edit emergency use authorization for. Text may be added and replaced, new objects can be included, pages can be rearranged, watermarks and page numbers can be added, and so on. When you're done editing, click Done and then go to the Documents tab to combine, divide, lock, or unlock the file.
4
Get your file. Select the name of your file in the docs list and choose your preferred exporting method. You can download it as a PDF, save it in another format, send it by email, or transfer it to the cloud.
With pdfFiller, it's always easy to work with documents.

Uncompromising security for your PDF editing and eSignature needs

Your private information is safe with pdfFiller. We employ end-to-end encryption, secure cloud storage, and advanced access control to protect your documents and maintain regulatory compliance.
GDPR
AICPA SOC 2
PCI
HIPAA
CCPA
FDA

How to fill out emergency use authorization for

Illustration

How to fill out Emergency Use Authorization for Peramivir

01
Obtain the relevant application form for Emergency Use Authorization (EUA) from the FDA website.
02
Complete the applicant information section with your contact details and the name of the organization applying.
03
Provide a detailed description of Peramivir, including its mechanism of action and proposed use.
04
Include clinical data supporting the safety and efficacy of Peramivir for the intended use.
05
Present information on the manufacturing process and quality control measures.
06
Collect and organize any relevant supporting documentation, such as previous research studies or emergency use cases.
07
Submit the completed application along with all required documents to the FDA electronically or by mail.
08
Monitor the application status and be prepared to respond to any FDA inquiries or requests for additional information.

Who needs Emergency Use Authorization for Peramivir?

01
Healthcare providers seeking to treat patients with specific conditions that could be managed with Peramivir.
02
Pharmaceutical companies or manufacturers intending to distribute or promote Peramivir for emergency use.
03
Public health organizations needing authorization to procure and use Peramivir during a health crisis.
Fill form : Try Risk Free
Users Most Likely To Recommend - Summer 2025
Grid Leader in Small-Business - Summer 2025
High Performer - Summer 2025
Regional Leader - Summer 2025
Easiest To Do Business With - Summer 2025
Best Meets Requirements- Summer 2025
Rate the form
4.7
Satisfied
47 Votes

People Also Ask about

The updated mRNA vaccines are each approved for individuals 12 years of age and older and are authorized under emergency use for individuals 6 months through 11 years of age. As part of today's actions, the bivalent Moderna and Pfizer-BioNTech COVID-19 vaccines are no longer authorized for use in the United States.
Peramivir treats the flu. Symptoms of the flu include fever, head and body aches, coughing and a stuffy or runny nose. A healthcare provider will give you this injection in a hospital or clinic setting. The brand name of this injection is Rapivab®.
Section 564 of the FD&C Act permits FDA to authorize the introduction into interstate commerce of a drug, device, or biological product intended for use in an actual or potential emergency when the Secretary of HHS has declared that circumstances exist justifying the authorization of emergency use.
Cautions Serious skin reactions reported including erythema multiforme and Stevens-Johnson syndrome; discontinue and initiate appropriate treatment. Influenza can be associated with neurologic and behavioral symptoms including hallucinations, delirium, and abnormal behavior, in some cases resulting in fatal outcomes.
Today, the U.S. Food and Drug Administration approved and granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent (single) component that corresponds to the Omicron variant KP. 2 strain of SARS-CoV-2.
[03/13/2024] EUA-labeled Paxlovid is no longer authorized for emergency use, regardless of the labeled or extended expiration date. For both NDA-approved and EUA-authorized uses, only NDA-labeled Paxlovid may be dispensed.
An Emergency Use Authorization (EUA) is a mechanism to facilitate the availability and use of medical countermeasures, including vaccines, during public health emergencies, such as the current COVID-19 pandemic.
The process for issuing an EUA is different than an FDA approval. Under an EUA, the FDA authorizes uses of medical products based on a reasonable belief that the product may be effective based on the best evidence available at the time, without waiting for all the information that would be needed for an FDA approval.

For pdfFiller’s FAQs

Below is a list of the most common customer questions. If you can’t find an answer to your question, please don’t hesitate to reach out to us.

Emergency Use Authorization (EUA) for Peramivir is a process by which the U.S. Food and Drug Administration (FDA) can allow the use of a medical product during public health emergencies when there are no adequate, approved, and available alternatives.
Manufacturers seeking to distribute Peramivir for emergency use during a public health crisis must file for Emergency Use Authorization with the FDA.
To fill out an Emergency Use Authorization application for Peramivir, manufacturers must submit a comprehensive application including details on the product's safety, efficacy, manufacturing processes, and proposed uses under EUA.
The purpose of Emergency Use Authorization for Peramivir is to provide access to the medication during public health emergencies, such as outbreaks of influenza, when conventional treatments may not be sufficient or available.
The information required to be reported includes the clinical data supporting its use, information on the manufacturing process, proposed labeling, and details about the potential benefits and risks associated with the use of Peramivir.
Fill out your emergency use authorization for online with pdfFiller!

pdfFiller is an end-to-end solution for managing, creating, and editing documents and forms in the cloud. Save time and hassle by preparing your tax forms online.

Get started now
Form preview
If you believe that this page should be taken down, please follow our DMCA take down process here .
This form may include fields for payment information. Data entered in these fields is not covered by PCI DSS compliance.